跳至主要内容
临床试验/NCT03759899
NCT03759899Unknown不适用

Establishment of Clinical Applicable Human Amniotic Epithelial Cell Products and Its Preliminary Application in Allogeneic Hematopoietic Stem Cell Transplantation

Peking University People's Hospital1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2020年7月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
30
试验地点
1
主要终点
Cell counts of T cells, NK cells, B cells and monocytes

研究概览

简要总结

hAECs Are Preliminarily Applied in Allogeneic Hematopoietic Stem Cell Transplantation

详细描述

Establishment of Clinical Applicable Human Amniotic Epithelial Cell Products and Its Preliminary Application in Allogeneic Hematopoietic Stem Cell Transplantation

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • leukemia patients with allogeneic HSCT
  • KFS score >90
  • after transplantation, the patient was implanted (peripheral blood neutrophil absolute value >500/ul for 3 consecutive days)
  • no uncontrolled infection after transplantation
  • activity II above aGVHD
  • patients agreed to participate in the study

排除标准

  • patients refused to participate in the study
  • patients have poor compliance
  • has received hormone therapy
  • patients had serious heart, lung, liver, kidney and other vital organs damage
  • researchers believe that patients who are not suitable for observation study

结局指标

主要结局

Cell counts of T cells, NK cells, B cells and monocytes

时间窗: Day 7

proliferation and apoptosis of T cells, NK cells, B cells and monocytes in peripheral blood of patients

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Xiaojun Huang,MD

Director of the Hematology Department

Peking University People's Hospital

研究点 (1)

Loading locations...

相似试验